Abstract
There are 25 million asthmatics in the USA, but estimates of the fraction that have occupational asthma (OA) vary widely. The reported prevalence of OA among all adult asthmatics ranges between 2 and 36% (1, 2). It is estimated that up to 25% of all “adult-onset” asthmatics have a workplace trigger for their disease. One explanation for the varied prevalence rates is that the OA diagnosis may not be as stringent in some retrospective studies as it is in documented worker compensation cases. In one of the largest retrospective series covering three decades of studies, Blanc and Toren concluded that one in ten adult asthmatics had an occupational trigger for their disease (3). The more conservative estimate, therefore, is that the prevalence of OA is 5–10% of all adult asthma cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Johnson AR, Dimich-Ward HD, Manfreda J, et al. Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med 2000; 162:2058–62.
Brooks SM, Hammad Y, Richards I, Giovinco-Barbas J, Jenkins K. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 1998; 113:42–9.
Blanc PD, Toren K. How much adult asthma can be attributed to occupational factors? Am J Med 1999; 107:580–7.
Meredith S, Nordman H. Occupational asthma: measures of frequency from four countries. Thorax 1996; 51:435–40.
Jajosky RA, Harrison R, Reinisch F, et al. Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments--California, Massachusetts, Michigan, and New Jersey, 1993–1995. MMWR CDC Surveill Summ 1999; 48:1–20.
Henneberger PK, Kreiss K, Rosenman KD, Reilly MJ, Chang YF, Geidenberger CA. An evaluation of the incidence of work-related asthma in the United States. Int J Occup Environ Health 1999; 5:1–8.
McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989–97. Occup Environ Med 2000; 57:823–9.
Balder B, Lindholm NB, Lowhagen O, et al. Predictors of self-assessed work ability among subjects with recent-onset asthma. Respir Med 1998; 92:729–34.
Marabini A, Dimich-Ward H, Kwan SY, Kennedy SM, Waxler-Morrison N, Chan-Yeung M. Clinical and socioeconomic features of subjects with red cedar asthma. A follow-up study. Chest 1993; 104:821–4.
Dewitte JD, Chan-Yeung M, Malo JL. Medicolegal and compensation aspects of occupational asthma. Eur Respir J 1994; 7:969–80.
Leigh JP, Romano PS, Schenker MB, Kreiss K. Costs of occupational COPD and asthma. Chest 2002; 121:264–72.
Tarlo SM, Balmes J, Balkissoon R et al. Diagnosis and management of work-related asthma. Chest 2008; 134:1S-41S.
Fishwick D, Barber CM, Bradshaw LM et al. Standards of care for occupational asthma. Thorax 2008; 63:240–50.
Beach J, Rowe BH, Blitz S et al. Diagnosis and management of work-related asthma. Evid Rep Technol Assess 2005; 129:1–8.
American Thoracic Society. Guidelines for assessing and managing asthma risk at work, school, and recreation. Am J Respir Crit Care Med 2004; 169:873–81.
Wheeler S, Rosenstock L, Barnhart S. A case series of 71 patients referred to a hospital-based occupational and environmental medicine clinic for occupational asthma. West J Med 1998; 168:98–104.
Rosenman KD, Reilly MJ, Kalinowski DJ. A state-based surveillance system for work-related asthma. J Occup Environ Med 1997; 39:415–25.
Banauch GI, Alleyne D, Sanchez R, et al. Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center. Am J Respir Crit Care Med 2003; 168:54–62.
Prezant DJ, Weiden M, Banauch GI, et al. Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med 2002; 347:806–15.
Nemery B. Late consequences of accidental exposure to inhaled irritants: RADS and the Bhopal disaster. Eur Respir J 1996; 9:1973–6.
Lioy PJ,Weisel CP, Millette S et al. Characterization of the dust/smoke aerosol that settled East of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001. Env Health Persp 2002; 110:703–714.
Geyh A, Chillrud S, Williams DA et al. Assessing truck driver exposure at the World Trade Center disaster site: Personal and area monitoring for particulate matter and volatile organic compounds during October 2001 and April 2002. J Occ Env Hygiene 2005; 2: 179–193.
de la Hoz RE. Occupational asthma and lower airway disease among World Trade Center workers and volunteers. Curr Allergy Asthma Rep 2010; 10:287–294.
Tarlo SM, Boulet L, Cartier A et al. Canadian Thoracic Society guidelines for occupational asthma. Can Resp J 1998; 5:289–300.
Milton DK, Solomon GM, Rosiello RA, Herrick RF. Risk and incidence of asthma attributable to occupational exposure among HMO members. Am J Ind Med 1998; 33:1–10.
Moscato G, Godnic-Cvar J, Maestrelli P, Malo JL, Burge PS, Coifman R. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of the European Academy of Allergology and Clinical Immunology. American Academy of Allergy and Clinical Immunology. European Respiratory Society. American College of Allergy, Asthma and Immunology. Eur Respir J 1995; 8:1605–10.
Anees W, Gannon PF, Huggins V et al. Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma. Eur Resp J 2004; 23:730–734.
Karol MH, Tollerud DJ, Campbell TP, et al. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Am J Respir Crit Care Med 1994; 149:611–5.
Banks DE, Sastre J, Butcher BT, et al. Role of inhalation challenge testing in the diagnosis of isocyanate-induced asthma. Chest 1989; 95:414–23.
Ortega HG, Weissman DN, Carter DL, Banks D. Use of specific inhalation challenge in the evaluation of workers at risk for occupational asthma: a survey of pulmonary, allergy, and occupational medicine residency training programs in the United States and Canada. Chest 2002; 121:1323–8.
Sastre J, Fernandez-Nieto M, Novalbos A, De Las Heras M, Cuesta J, Quirce S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest 2003; 123:1276–9.
Bernstein DI, Cartier A, Cote J, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Resp Crit Care Med 2002; 166:445–50.
Park HS, Jung KS, Hwang SC, Nahm DH, Yim HE. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy 1998; 28:724–30.
Lemiere C. The use of sputum eosinophils in the evaluation of occupational asthma. Curr Opin Allergy Clin Immunol 2004; 4:81–5.
Piipari R, Piirila P, Keskinen H, Tuppurainen M, Sovijarvi A, Nordman H. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J 2002; 20:1532–7.
Fryer AA, Bianco A, Hepple M, Jones PW, Strange RC, Spiteri MA. Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med 2000; 161:1437–42.
Mapp CE, Pozzato V, Pavoni V, Gritti G. Severe asthma and ARDS triggered by acute short-term exposure to commonly used cleaning detergents. Eur Respir J 2000; 16:570–2.
Mapp CE, Fryer AA, De Marzo N, et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol 2002; 109:867–72.
Broberg KE, Warholm M, Tinnerberg H et al. The GSTP1 Ile105Val polymorphism modifies the metabolism of toluene diisocyanate. Pharmacogen Genomics 2010; 20: 104–111.
Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 1995; 151:219–21.
de Meer G, Postma DS, Heederik D. Bronchial responsiveness to adenosine-5¢-monophosphate and methacholine as predictors for nasal symptoms due to newly introduced allergens. A follow-up study among laboratory animal workers and bakery apprentices. Clin Exp Allergy 2003; 33:789–94.
Malo JL, Ghezzo H, D’Aquino C, L’Archeveque J, Cartier A, Chan-Yeung M. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol 1992; 90:937–44.
Griffin P, Allan L, Beckett P, Elms J, Curran AD. The development of an antibody to trimellitic anhydride. Clin Exp Allergy 2001; 31:453–7.
Karol MH, Macina OT, Cunningham A. Cell and molecular biology of chemical allergy. Ann Allergy Asthma Immunol 2001; 87:28–32.
Radon K, Busching K, Heinrich J, et al. Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults? Chest 2002; 122:1086–90.
Calverley AE, Rees D, Dowdeswell RJ, Linnett PJ, Kielkowski D. Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposure. Occup Environ Med 1995; 52:661–6.
Preventing Asthma in Animal Handlers. NIOSH Alert 1998; Publication No. 97–116. Bethesda, MD. U.S. Department of Health and Human Services.
Cherry N, Beach J, Burstyn I et al. Data linkage to estimate the extent and distribution of occupational disease: new onset adult asthma in Alberta, Canada. Amer J Ind Med 2009; 52: 831–840.
Mazurek JM, Filios M, Willis R et al. Work-related asthma in the educational services industry: California, Massachusetts, Michigan, New Jersey 1993–2000. Am J Ind Med 2008; 51:47–59.
Bello A, Quinn M, Perry MJ, Milton DK. Characterization of occupational exposures to cleaning products used for common cleaning tasks--a pilot study of hospital cleaners. Environ Health 2009; 8:11.
Amr S, Suk WA. Latex allergy and occupational asthma in health care workers: adverse outcomes. Environ Health Perspect 2004; 112:378–81.
Bush RK, Stave GM. Laboratory animal allergy: an update. Ilar J 2003; 44:28–51.
Tarlo SM, Liss GM. Prevention of occupational asthma – practical implications for occupational physicians. Occ Med 2005; 55: 588–594.
Grammer LC, Harris KE, Yarnold PR. Effect of respiratory protective devices on development of antibody and occupational asthma to an acid anhydride. Chest 2002; 121:1317–22.
National Heart LaBI, National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Expert Panel Report 3: 2007; Publication No. 08–0415. Bethesda, MD: U.S. Department of Health and Human Sevices.
Malo JL, Cartier A, Cote J, et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med 1996; 153:953–60.
Marabini A, Siracusa A, Stopponi R, Tacconi C, Abbritti G. Outcome of occupational asthma in patients with continuous exposure: a 3-year longitudinal study during pharmacologic treatment. Chest 2003; 124:2372–6.
Vandenplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. Eur Respir J 2003; 22:689–97.
Gassert TH, Hu H, Kelsey KT, Christiani DC. Long-term health and employment outcomes of occupational asthma and their determinants. J Occup Environ Med 1998; 40:481–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kenyon, N.J., Morrissey, B.M., Schivo, M., Albertson, T.E. (2012). Occupational Asthma. In: Gershwin, M., Albertson, T. (eds) Bronchial Asthma. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6836-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6836-4_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6835-7
Online ISBN: 978-1-4419-6836-4
eBook Packages: MedicineMedicine (R0)